I. Vanliefde et al., ALPHA-2A ADRENOCEPTORS AND NONADRENERGIC IDAZOXAN BINDING-SITES IN CALF BRAIN AND RETINA ARE DISTINCT FROM THOSE IN HUMAN BRAIN, Neurochemistry international, 22(5), 1993, pp. 501-509
Alpha2 Adrenoceptors in membrane preparations of human and calf fronta
l cortex and of calf retina can be labelled by the antagonists [H-3]id
azoxan, [H-3]rauwolscine and [H-3]RX 821002. Present and previous data
indicate that [H-3]idazoxan possesses the highest affinity for the al
pha2 adrenoceptors in the calf tissues, whereas [H-3]rauwolscine displ
ays the highest affinity for those in the human frontal cortex. Compet
ition binding experiments with adrenergic and serotonergic drugs furth
er support the notion that the alpha2 adrenoceptors in calf frontal co
rtex and retina are similar, but distinct from the receptors in human
frontal cortex. The alpha2 adrenoceptors in the three investigated tis
sues display low affinity for the antagonist prazosin, which suggests
that they all belong to the alpha2A subclass. The competition binding
curves of the alpha2A adrenoceptor subtype-selective agonist oxymetazo
line are shallow, but undergo a rightward shift and steepening in the
presence of GTP. The shallow curves can therefore be attributed to the
coupling of the alpha2 adrenoceptors to G proteins. The different bin
ding characteristics of the alpha2A adrenoceptors from the investigate
d human and bovine tissues are likely to reflect species-related diffe
rences in protein structure. [H-3]Idazoxan binds also to non-adrenergi
c sites in membrane preparations from the three tissues. However, the
affinity of [H-3]idazoxan for these sites in calf cortex and retina is
appreciably lower than for those in human cortex. The species-related
differences of the non-adrenergic idazoxan binding sites may be due t
o differences in protein structure or even to differences in gene-prod
uct.